Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
Recruiting
Trans Arterial Embolization for Facet Arthropathy
Who can join
Ages 18 to 85 · All sexes
Full eligibility criteria
Inclusion Criteria:
* Age 18-85
* Confirmed diagnosis of spinal facet arthropathy on MRI OR CT
* Confirmed diagnosis of lumbosacral facetogenic pain based on diagnostic nerve blocks.
* Failed medical management of pain.
* Back pain persistent for at least 6 months
* Pain worse than at least 6/10 on a visual analog pain scale
* Failed at least one of either intra-articular injections of steroids/ anesthetics or neuro-ablative procedure.
* Maximum of 2 spinal levels of facetogenic pain in the lumbar and sacral spine (i.e. L4-5 and L5-S1).
* Modified Rankin Scale 0-2
Exclusion Criteria:
* \- Pregnancy
* History of prior spinal embolization at the target level.
* History of surgery/ stenting of the aorta at the level of embolization.
* Severe allergic reaction to iodinated contrast (i.e. anaphylaxis)
* Creatinine \> 1.5 mg/dl and/or creatinine clearance \< 60 mL/min (except if patients is already on hemodialysis).
* Modified Rankin Scale \>2
* Angiographic/ Procedural Exclusion Criterion: Vascular supply to the spinal cord from the vessels supplying the facet joints targeted for embolization.About the study
This single-site, single-arm study evaluates the feasibility, safety, tolerability, and efficacy of trans-arterial embolization (TAE) using Embozene microparticles for treating facetogenic pain due to facet arthropathy (osteoarthritis of the facet joints) in the lumbar spine.
What is being tested
- Spinal angiography and embolization/ Embozene Microspheres (device)
Sponsor: Northwell Health · Participants: 40 · Started: Aug 12, 2025
Contact the study team
- Betsy Moclair · Phone: 516-253-7753
Official record on ClinicalTrials.gov — NCT06965452
Locations in the U.S.
| New York | North Shore University Hospital, Manhasset |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.